Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Japan Halts Use of Pfizer and sanofi Vaccines

March 10, 2011

Japan has suspended the use of two pediatric vaccines made by Pfizer and sanofi following the deaths of four children in three days.

Improving Solid Dosage Forms With Dry Granulation

March 07, 2011

Pharmaceutical Technology Europe

Although tablet manufacture is traditionally a batchbased wet granulation process, there are many advantages to be gained by adopting dry granulation, including lower costs and increased yields.

The Benefits Of Tablet Tooling Standardisation

March 07, 2011

Pharmaceutical Technology Europe

Tooling standardisation in the tablet manufacturing industry is a topic that has concerned tabletting professionals for decades.

Next Steps for the US Biosimilar Regulatory Scheme

March 02, 2011

With a regulatory pathway for follow-on biologics, industry is wondering what FDA will do next.

A Statistical Approach to Evaluating the Manufacture of Furosemide Tablets

March 02, 2011

The authors evaluated the manufacturing data of 40-mg tablets of furosemide, a potent diuretic.

The Benefits of Tablet Tooling Standardization

March 02, 2011

A single, global tooling standard would offer many benefits, but one has been slow to emerge.

Quality by Design for Biologics and Biosimilars

March 02, 2011

The author provides an overview of QbD implmentation for biopharmaceuticals.

The US Biosimilar Regulatory Scheme and Comparison with the European Experience: Where Do Where Go From Here?

March 02, 2011

PTSM: Pharmaceutical Technology Sourcing and Management

The authors outline the key decision points FDA must consider in putting forth a US regulatory pathway for biosimilars.

Regulatory Roundup: HHS Releases a New National Vaccine Plan

February 24, 2011

HHS Releases a New National Vaccine Plan

Equipment and Processing Report

February 2011 Editor's Picks: Products from Alfa Laval and GE Healthcare

February 16, 2011

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the February 2011 edition from Alfa Laval and GE Healthcare.